Tag Archives: after

AstraZeneca aims to pump up Farxiga marketing after cardio outcomes study

Now that AstraZeneca has scored its Farxiga outcomes data, it’s aiming to change the game on its SGLT2 diabetes rivals. First up? Expanding its salesforce to prepare for a full-court press on doctors.  The British drugmaker aims to “increase the scope” of its physician marketing after phase 3 trial data showed Farxiga cut the risk of cardiovascular… Read More »

Love, Death and the Internet: The virtual ghosts left behind long after we die

ROBERT Mark Boydell joined Facebook in March 2017. He’s slender; in his late-teens or early-20s with dark hair, high cheekbones and a rock-and-roll hipster aesthetic. In one photo, he is stepping out of a closet, face painted and cigarette hanging between his fingers, bundled into a dark jacket and film camera haze – the kind… Read More »